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Clinic of Dermatology, Graz, AustriaPurpose. To study intermediate clinical outcomes, rates of recurrent varicosities and neovascularisation, ultrasound
changes of the GSV, and the quality of life changes in patients from EVOLVeS trial.
Methods. Forty five patients were re-examined 1 year and 65 two years after treatment. Follow-up visits included clinical
examination with CEAP classification and calculation of venous clinical severity score (VCSS), ultrasound examination,
and a quality of life questionnaire.
Results. The clinical course of the disease (CEAP, VCSS) was similar in the two treatment groups. 51% of the GSV trunks
occluded by RFO underwent progressive shrinkage with the external diameter decreased from 6.3 SD 1.4 mm at 72 h after
treatment to 2.9 SD 1.5 mm at 2 years. An additional 41% of the GSV became undetectable by ultrasound at 2-year follow
up. In two patients we observed re-opening of an initially closed GSV lumen. Neovascularisation was found in one RFO case
and in four S and L cases. Cumulative rates of recurrent varicose veins at combined 1 and 2 years follow-up were 14% for
RFO and 21% for S and L (NS).
The difference in global QOL score in favour of RFO re-appeared at 1 year and remained significant at 2 years after
treatment.
Conclusion. The 2-year clinical results of radiofrequency obliteration are at least equal to those after high ligation and
stripping of the GSV. In the vast majority of RFO patients the GSV remained permanently closed, and underwent
progressive shrinkage to eventual sonographic disappearance. Recurrence and neovascularisation rates were similar in the
two groups although limited patient numbers prevent reliable statistical analysis. Improved quality of life scores persisted
through the 2-year observations in the RFO group compared to the S and L group.Keywords: Chronic venous disease; Varicose veins; Surgery; Radiofrequency obliteration; Randomised trial; Quality of life.Introduction
Varicose veins is a common clinical problemwhich has
a significant effect upon quality of life.1 Reflux in the
great saphenous vein (GSV) is one of the most frequent
causes of primary chronic venous disease (CVD). This
may progress to cause patient disability if left
untreated.2 The frequency of varicose veins, which ising author. Fedor Lurie, MD, PhD, Straub Foundation,
and Hospital, and University of Hawaii John A. Burns
dicine, Honolulu, HI, USA.
: flurie@straub.net.
0067+ 07 $35.00/0 q 2004 Elsevier Ltd. All rights reserincreasing as the average age of the population rises,
makes this disease a significant public health issue.
High ligation and stripping of the GSV (S and L) has
been found to be effective in the treatment of GSV
incompetence. This operation directly addresses the
problem of the incompetent GSV by removing it from
the circulation. Although long-term results of surgical
treatment show a high rate of recurrence,3–11 S and L
has become a standard of care for patients with GSV
insufficiency. Morbidity associated with incisions and
surgical removal of the vein, and temporary post-
surgical decline in the quality of life, are the major
drawbacks of S andL.1,12Attempts to minimise surgical
trauma, and to preserve the GSVas a potential conduitEur J Vasc Endovasc Surg 29, 67–73 (2005)
doi:10.1016/j.ejvs.2004.09.019, available online at http://www.sciencedirect.com onved.
F. Lurie et al.68by high ligation without removal of the vein, have
been shown to lead to even higher recurrence rates.3,13
Failure to ligate all proximal tributaries of the GSV is
thought to be one of the major causes of recurrence
after stripping and high ligation.14 This concept has
never been proven by an appropriately designed
study.
The recently developed technology of endovascular
obliteration of the GSV using temperature-controlled
radiofrequency energy (Closure(r) procedure) is
aimed at removing the vein from the circulation whilst
minimising the consequences for the patient. A multi-
centre randomised controlled trial (EVOLVeS) demon-
strated the superiority of the Closure procedure
compared to vein stripping in its impact on the quality
of life, time of return to pre-operative level of physical
activity and time of return to work (RTW).12 The
original study design was limited to a 4-month period
after surgery, and therefore did not address the
question of mid- or long-term effect of the procedure
and of recurrence rate.
Reports of non-randomised case series of Closure
procedures demonstrated a low recurrence rate after
24 months.15–17 Ultrasound follow-up to 2 years
demonstrated that the GSV remains closed and that
the proximal tributaries maintain their patency and
competence.16 These observations cannot be directly
compared to reported results of vein stripping because
of possible differences in patient population, surgical
techniques and clinical settings. Follow-up of the
patients enrolled in the EVOLVeS study can reveal
important information on the durability of the Closure
procedure, recurrence rates following both treatments,
and duration of their effect on quality of life. This
report presents results of 1 and 2-year clinical and
ultrasound follow-up data and quality of life surveys
in the patients enrolled in the EVOLVeS study.Materials and Methods
A detailed description of the EVOLVeS protocol,
patient selection criteria, and treatments has been
published in our initial report.12 Several important
aspects of this study deserve mention here.
A total of 85 patients entered the study with 45
patients (46 limbs) allocated to radiofrequency oblit-
eration (RFO) and 40 patients to high ligation and
stripping (S and L), and 79 patients (80 limbs) received
treatment (Fig. 1). Recruitment was terminated mainly
due to reluctance on the part of patients to be blindly
allocated to one or other of the treatment options. The
treatment was randomly assigned via an internetEur J Vasc Endovasc Surg Vol 29, January 2005based central system for all of the five participating
sites (France-2, Austria-1, United States-2).
Each of the participating sites had obtained an
approval of Institutional Review Board or Ethics
committee of the institution. Patients gave their
informed written consent for inclusion in the study.
Individuals with symptomatic varicose veins and
incompetence of the great saphenous vein confirmed
by duplex ultrasound examination who were candi-
dates for conventional vein stripping were eligible for
inclusion in the study.
During each patient’s visit a standard set of
information was collected. Physicians assessed
patient’s signs and symptoms utilising venous clinical
severity score (VCSS),18 and completed CEAP classi-
fication. They assessed patient’s limbs for the presence
of recurrent varicose veins. Ultrasound examination
included measuring the external (adventitia-to-adven-
titia) and internal (intima-to-intima) diameters of the
great saphenous vein (GSV) and characteristics of
outflow and reflux. In addition, each patient com-
pleted the 20-question CIVIQ2 quality of life ques-
tionnaire that has been validated for use in patients
with chronic venous disease.19,20 In the analysis, each
of the dimension scores, and the global scores, were
transformed into a scale of 0–100.19 Zero represents the
least possible impact on daily activities and well being,
i.e. highest quality of life, while 100 represents a
maximum negative impact.
The only difference between the two groups was in
treatment of the GSV. Both RFO and S and L were
performed in the great saphenous vein from the knee,
or upper calf, to the sapheno-femoral junction.
Adjunctive procedures on varices and perforators
were limited to below-the-knee sites in order to
avoid confusion post-operatively between morbidity
due to the saphenous vein treatment of the Closure
procedure versus stripping and that due to the
adjunctive procedure.
Post-operative visits were at 72 h, 1 week, 3 weeks, 4
months, 1 and 2 years (Fig. 1). At 1 and 2 years follow-
up additional information was collected. The presence
of neovascularisation in the groin was assessed by
duplex ultrasound examination. This was defined as
multiple small vessels in the groin reconnecting more
proximal vein or its tributaries and the distal patent
vein below the site of interruption (S and L) or
occlusion (RFO). In cases where varicose veins were
present, the question of whether varicosities were new
or pre-existing was considered. New varicose veins
below the knee were classified as recurrent varicos-
ities. Special attention was paid to visualisation of the
GSV after RFO to detect recanalisation of this vein. In
Fig. 1. Study design.
EVOLVeS: Two-year Follow-up 69many cases the GSV was completely obliterated by the
treatment and could not be identified on ultrasound.
The patient records were reviewed by the sponsor
for completion of the study data points. After the data
acquisition the investigators conducted a thorough
audit of the raw data handling and storage methods,
the data processing accuracy, and the presentation of
the specific results. This was done twice, once after
completion of 4-month follow-up (LK and FL), and
again after completion of 2-year follow-up (RLK and
FL). They reported that all of these were in order,
and that the results accurately reflected the raw data
received from the investigator sites. The sponsor,
VNUS Medical Technologies, Inc. provided support
limited to these functions, but did not interfere with
the analysis of the data or the formulation of the
conclusions.Statistical methods
Student’s t-test, and one-way ANOVA with Tukey-
Kramer tests were used to analyse differences between
the groups. The Mann–Whitney U test was utilised
where appropriate. Differences were considered sig-
nificant at the 95% level (p!0.05). When comparisons
were made between the score before treatment (base-
line) and the score after treatment, repeated measures
ANOVA was used. Alternatively, the absolute differ-
ence between the baseline score and the score after
treatment for each individual patient was used (such
as in Fig. 6). The Cochran-Mantel-Haenszel and Chi-
square statistics were used for comparing the frequen-
cies. Kaplan–Meier analysis and Long Rank test wereused for analysis of time-series. All values presented
as the mean and standard deviation (SD); the 95%
confidence interval (CI) is also included where
appropriate.Results
The first 4 months of follow-up revealed an advantage
of RFO in impact on quality of life, earlier return to
usual level of physical activity (RTA) and earlier RTW.
There were no major complications in either group. An
important question at the time of the initial study was
rate of the technical success of the Closure technique,
mainly because it was a relatively new procedure.
Immediate intra-operative success was reported in all
but two cases.
Four months after Closure treatment four extremi-
ties demonstrated reflux in the proximal GSV. The
lengths of refluxing segments were 4, 22, 28 and 30 cm.
At 2-year follow-up one of these extremities had a
closed GSV with no flow, another extremity exhibited
the same length (4 cm) of open GSV segment but no
reflux, and in the remaining two extremities the GSV
remained open and incompetent.
In two patients we observed re-opening of an
initially closed GSV lumen. In both cases the GSV
remained closed at 4 months, but at 2-year follow-up a
competent segment of GSV 23 cm long was found in
one case, and a 34 cm long incompetent GSV segment
was found in another case. In three S and L cases, open
incompetent segments of saphenous vein were found
in the immediate vicinity of original GSV location at
the 2-year follow-up.
For the veins occluded by RFO, 51% of the GSV
trunks showed a continuing decrease in diameter
during the period of observation. Duplex ultrasono-
graphy showed that the external (adventitia-to adven-
titia) diameter of obliterated GSV decreased from a
mean of 6.3 SD 1.4 mm 72 h after surgery to 2.9 SD
1.5 mm 2 years later (p!0.00001; Fig. 2). An additional
41% of the GSVs became undetectable on ultrasound
imaging at the 2-year follow up. Veins that decreased
in size, but did not completely disappear were initially
larger compared to those that became sonographically
invisible. At 72 h after treatment their mean external
diameters were 6.3 SD 1.4 mm and 4.3 SD 1.4 mm (pZ
0.0005) respectively. The rate of diameter decrease was
not significantly different in these groups (1.8 SD
0.9 mm/year and 2.2 SD 0.7 mm/year, pZ0.085). In
three cases the GSV diameter did not change.
Neovascularisation was observed in one RFO case
and in four S and L cases.
Cumulative rates of recurrent varicose veins atEur J Vasc Endovasc Surg Vol 29, January 2005
Fig. 2. External (adventitia-to-adventitia) GSV diameter
change in 20 RFO extremities in which GSV is still
identifiable by ultrasound at 2-year follow-up.
F. Lurie et al.70combined 1 and 2 years follow-up were 14.3% for RFO
and 20.9% for S and L (pO0.05 Long Rank test, Fig. 3).
The clinical course of the disease was similar in both
groups following treatment (Table 1). At the 2-year
follow up, 12 patients (33%) after RFO and 8 patients
(28%) after S and L had no sign of venous disease
(CEAP clinical class C0). A statistically significant
difference in VCSS score between the groups was
observed at 72 h and 1 week after treatment (Fig. 4).
This disappeared at all subsequent follow-up
assessments.
Major differences between RFO and S and L groups
at early follow-up were in time to return to usual levels
of physical activity, time to RTW, and quality of life
(QOL).12 Although the difference in global QOL score
was not significant at 3 weeks after treatment, it
surprisingly re-appeared at 1 year and remainedFig. 3. Cumulative prevalence of varicosities (Kaplan–Meier
analysis).
Eur J Vasc Endovasc Surg Vol 29, January 2005significant at 2 years after treatment (Fig. 5). Pain
was the only QOL dimension consistently reduced in
the RFO group throughout all subsequent follow up
both in absolute score and in change from the pre-
treatment value (Fig. 6).Discussion
Our earlier report showed advantage for RFO com-
pared to S and L in the early follow-up period. These
findings were consistent with observations of non-
randomised studies.15–17 The remaining question was
the durability of the results. The fact that RFO violates
two principles of a mainstream paradigm for surgical
treatment of GSV reflux by leaving an open proximal
segment of GSV and by leaving untouched the
proximal GSV tributaries generated reasonable scepti-
cism regarding long-term results.21 Particular concern
is the role of proximal tributaries in development of
recurrent varicose veins.
Publications on the surgical treatment of GSVreflux
provide the basis for questioning the role of proximal
tributaries in development of recurrences. The
majority of recurrent varicosities are located below
the knee.6 In a series of 264 limbs with recurrences 24.3
SD 12.5 year after surgery, Jiang et al. showed that the
source of recurrence was confined to the groin in only
13.6%, and incompetent groin tributaries were present
only in 12% of cases.8 In a detailed ultrasound study
Labropoulos et al. reported that in 65% of recurrences
following stripping the GSV, the source of recurrence
was other than in the groin. The clinical dynamics of
primary chronic venous disease after surgical treat-
ment have not been studied sufficiently to separate
changes associated with surgery from those caused by
natural history. Published reports suggest that new
varicose veins can develop regardless of presence or
absence of a refluxing GSV.22
In this study, the recurrence rate was numerically
lower in the RFO group compared to the S and L
group, but the difference did not reach the level of
statistical significance due to insufficient numbers in
our series. In three of five cases of recurrent veins in
the RFO group a segment of thigh GSV was either not
closed or re-opened. The likelihood of recurrence was
4.5 times higher in extremities with open GSV
segments compared to extremities with a successful
Closure treatment. This difference, however, did not
reach the level of statistical significance (ORZ4.5, 95%
CIZ0.7–28). Although our study was not powered to
address these questions, the detected magnitude of
differences between RFO and S and L groups and
between extremities with permanently closed GSVand
Table 1. Maximal clinical class (‘C’ of ‘CEAP’) before treatment and during follow-up
Maximal Clinical
class
RFO (% of observed
extremities)
S&L (% of observed
extremities)
Pearson Chi-Square p
Before treatment C0 0 0 0.2 0.9
C1 0 0
C2 81.8 77.8
C3 9.1 11.1
C4 9.1 11.1
72 h C0 54.5 66.7 1.7 0.6
C1 25 13.9
C2 11.4 11.1
C3 0 0
C4 9.1 8.3
1 week C0 44.2 66.7 6.3 0.2
C1 37.2 16.7
C2 11.6 8.3
C3 0 2.8
C4 7 5.6
3 weeks C0 54.5 52.8 0.1 0.99
C1 27.3 30.6
C2 9.1 8.3
C3 0 0
C4 9.1 8.3
4 months C0 34.1 41.2 2.95 0.6
C1 38.6 32.4
C2 18.2 20.6
C3 0 2.9
C4 9.1 2.9
1 year C0 28 15 5.8 0.2
C1 56 40
C2 8 30
C3 0 5
C4 8 10
2 years C0 33.3 27.6 2.97 0.6
C1 41.7 31
C2 22.2 31
C3 0 3.4
C4 2.8 6.9
EVOLVeS: Two-year Follow-up 71those with open GSV segments was substantial. This
justifies further investigation of recurrent varicosity
rates following both treatments, and with regard to
status of the GSV.
Some experts have expressed the opinion thatFig. 4. Changes in VCSS score. P-values are based on Mann–
Whitney U-test.because the process of neovascularisation is associated
with a groin incision, RFO may lead to a much less
frequent neovascularisation compared to S and L.23
In our 2-year follow up of the EVOLVeS trial
patients, neovascularisation was observed in four S
and L patients and in one RFO patient. The numbersFig. 5. Global QOL score. P-values are based on Mann–
Whitney U-test.
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Fig. 6. Change in pain QOL score compared to pre-treatment
value. Negative values reflect decrease in quality of life. P-
values are based on Mann–Whitney U-test.
F. Lurie et al.72are too small to make a statement about the difference,
but it is seen that neovascularisation can occur after
RFO. It is important to mention here that the only case
of neovascularisation after RFO occurred in a patient
with initial technical failure, and the GSV remained
open and incompetent during 2 years of observation.
Whether it is new vessels, or incompetent tribu-
taries, they need to be connected to a remaining
segment of GSV to cause clinical problems.10 In all but
five cases in this study, the lumen of the GSV was
permanently closed at 2 years. Two of these five cases
resulted from unsuccessful procedures (technical fail-
ures),12 one was reported closed immediately after
procedure but appeared open at 72 h after treatment,
and in another two cases the GSV lumen re-opened
during follow up (6%).
Although the issues of recurrence or neovascular-
isation are important, the EVOLVeS trial protocol was
not designed to study them in-depth, but only to
compare their rates in the two treatment groups. The
results showed absence of significant differences
between RFO and S and L patients at 2 years after
treatment. It has been suggested that the pathological
events leading to recurrence usually take place within
2 years and do not change thereafter.7 In combination
with our finding of progressive shrinkage and
disappearance of the GSV trunk, this gives us
confidence that our results can be expected to be
maintained for a longer time than we have so far
studied. As time progresses clinical changes are more
likely to reflect the natural progression of disease than
the difference in treatment techniques.
This study is also in line with published obser-
vations of changes in patients’ quality of life after
treatment. Major changes in QOL can be observed
within 6 months after surgery and lesser change
thereafter.1Eur J Vasc Endovasc Surg Vol 29, January 2005One of the limitations of this study is that selection
of the patients was based on indications for RFO that
existed at the time of study initiation (2000). At the
present time indications for RFO are much broader,
which put the limits of generalisation of this study
under question. However the same selection criteria
were used for both RFO and S and L groups, so the
results of comparison between the two treatments
should be applicable to a broader population.
A 2-year clinical follow up of patients from the
EVOLVeS trial showed that the results of radio-
frequency obliteration were at least equal to those
after high ligation and stripping of the great saphe-
nous vein. Ultrasound follow-up demonstrated that in
the vast majority of RFO patients the GSV remained
permanently closed, and underwent progressive
shrinkage to eventual sonographic disappearance.
Recurrence and neovascularisation rates demon-
strated trends toward being lower after RFO com-
pared to S and L. Superior quality of life was
demonstrated to be an early advantage of RFO, and
this has persisted throughout the 2-year study period.References
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